Hyaluronic Acid Joint Comfort Meta-analysis: What the Evidence Says

Quick Answer

Hyaluronic Acid Joint Comfort Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are guideline, so conclusions should be framed as evidence-aware guidance rather than medical advice.

Key Takeaways

• This page is generated only from sources stored in the Migaku evidence knowledge base.
• Current evidence mix: 1 guideline, 1 preclinical study.
• Claims should be interpreted with the source type, study design, population, and publication date in mind.
• This article is educational and does not replace care from a qualified clinician.

Evidence Map

What The Sources Report

• The purpose of this working group was to consider the latest qualitative and quantitative evidence regarding the use of IAHA in the treatment of knee OA. [Fuggle Nicholas (2026); evidence level 2]
• The concept of a ‘window of opportunity' is associated with a desire to identify individuals in pre-disease, or in an early stage of disease, when non-surgical intervention has the ability to change the course of a condition and, potentially, even reverse a disease trajectory. [Fuggle Nicholas (2026); evidence level 2]
• Lifetime prevalence of shoulder pain approaches 70%, with monthly prevalence estimates of 18-31% in the general population; the burden rises with age and is associated with disability, sleep disruption, productivity loss, and substantial healthcare utilization. [Muacevic Alexander (2025); evidence level 4]
• The novelty of this review lies in consolidating contemporary evidence and guideline-informed recommendations across all major shoulder pathologies into a single, clinically focused synthesis to support everyday orthopaedic and sports medicine decision-making. [Muacevic Alexander (2025); evidence level 4]

How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

Practical Interpretation

For hyaluronic acid joint comfort meta-analysis, the current source set is useful for orientation, but it is not yet broad enough for strong claims. Use cautious language and keep conclusions close to the cited sources.

Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

References

• Fuggle Nicholas (2026). Expert consensus on hyaluronic acid injections for knee osteoarthritis: a patient-centered approach. DOI: 10.1007/s40520-026-03366-8. PMCID: PMC13061766. PMID: 41920453. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13061766/
• Muacevic Alexander (2025). Current Non-operative Management of Shoulder Pathologies: A Narrative Review. DOI: 10.7759/cureus.98500. PMCID: PMC12765153. PMID: 41492609. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC12765153/

Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.